[Primary XXXX of vagina--attaching 24 cases clinical analysis].

@entity1 @entity420 @entity5 @entity3556
BACKGROUND _ OBJECTIVES: The incidence of primary @entity420 was lower and its treatment was difficult and its prognosis was worse. This study was designed to explore the clinical characters, treatment, prognosis of primary @entity420 in this paper as the incidence of primary @entity420 was lower, its treatment was difficult and its prognosis was worse. METHODS: From 1964 to 1999, twenty-four @entity1 were reviewed retrospectively in our hospital. RESULTS: The main clinical symptoms were @entity3556 and discharge. The median age was 49 years old. Five @entity1 were classified as stage I, 10 @entity1 were stage II, 5 @entity1 were stage III, and 4 @entity1 were stage IV. The lesion was located in the anterior wall in 8(33.3%) @entity1 , the posterior wall in 5(20.8%) @entity1 , the left wall in 1 @entity1 and the multiple walls in 10(41.7%) @entity1 . Twenty-four @entity1 were generally received radiotherapy, including external-beam and intracavitary irradiation. Two @entity1 were concurrently received chemotherapy and irradiation, Eight @entity1 were received chemotherapy as the @entity5 was not control and recurrent or metastatic. The survival rate of 3 years was 47.3% and that of 5 years was 34.2%. The survival mean time of @entity1 with stage I and stage II was 60.3 months obviously much longer than 14.8 months of @entity1 with stage III and stage IV, and they were significantly statistical difference (P < 0.01). But the survival mean time of @entity1 more than 40 years and less than or equal to 40 years was not significantly statistical difference. Eight @entity1 had local recurrence, which is the main reason of failure treatment. CONCLUSIONS: Primary vaginal @entity420 should mainly be adopted combined treatment depending on radiotherapy, but the prognosis was worse, the stage was the important factors affecting on the prognosis.
